First COVID Deaths in the US Mobilized a Dialysis Network

When the first COVID-19 death in the United States was a patient at a Northwest Kidney Center in Seattle, measures to prevent infection were rapidly put in place, and here is what they learned.
Source: WebMD Health - Category: Consumer Health News Source Type: news

Related Links:

Source: Mayo Clinic Proceedings - Category: Internal Medicine Authors: Source Type: research
Authors: Albalate M, Arribas P, Torres E, Cintra M, Alcázar R, Puerta M, Ortega M, Procaccini F, Martin J, Jiménez E, Fernandez I, de Sequera P, Grupo de Enfermería HUIL, Grupo enfermería HUIL Abstract Dialysis patients are a risk group for SARS-CoV-2 infection and possibly further complications, but we have little information. The aim of this paper is to describe the experience of the first month of the SARS-CoV-2 pandemic in a hospital haemodialysis (HD) unit serving the district of Madrid with the second highest incidence of COVID-19 (almost 1,000 patients in 100,000h). In the form of...
Source: Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia - Category: Urology & Nephrology Tags: Nefrologia Source Type: research
During the COVID-19 era, all 50 US states should cover standard outpatient dialysis for undocumented immigrant patients with kidney failure, many of whom now rely on emergency-only dialysis, according to new recommendations.Reuters Health Information
Source: Medscape Transplantation Headlines - Category: Transplant Surgery Tags: Nephrology News Source Type: news
(Johns Hopkins Medicine) Not enough manufactured dialysate for COVID-19 patients with acute kidney injury? Two Johns Hopkins Medicine physicians find a way to replenish dwindling supplies.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news
NEW BRUNSWICK, NJ, May 27, 2020 — The Janssen Pharmaceutical Companies of Johnson &Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted approval for a new pediatric formulation of SIRTURO® (bedaquiline). SIRTURO® is now indicated for use as part of combination therapy in the treatment of adult and pediatric patients (5 years and older and weighing at least 15 kg) with pulmonary multidrug-resistant tuberculosis (MDR‑TB). In the U.S., the medicine should be reserved for use when an effective treatment regimen cannot otherwise be provided. This indication received accelera...
Source: Johnson and Johnson - Category: Pharmaceuticals Tags: Innovation Source Type: news
ConclusionOnly 46.875% of the hemodialysis patients with COVID-19 had fever in the early stage; and diabetics may be the most susceptible population. A decrease in blood lymphocyte count and ground-glass opacity on chest CT scan is beneficial in identifying the high-risk population.
Source: Clinical and Experimental Nephrology - Category: Urology & Nephrology Source Type: research
May 27, 2020. . Sponsored by Centers for Medicare and Medicaid Services
Source: Rural events via the Rural Assistance Center - Category: Rural Health Source Type: events
AbstractCoronavirus disease 2019 (COVID-19) has rapidly spread not only in China but throughout the world. Children with kidney failure (chronic kidney disease (CKD) stage 5) are at significant risk for COVID-19. In turn, a set of recommendations for the prevention and control of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and COVID-19 in pediatric hemodialysis (HD) centers and in home peritoneal dialysis (PD) settings have been proposed. The recommendations are based on the epidemiological features of the SARS-CoV-2 virus and COVID-19 disease, susceptibility factors, and preventive and control strateg...
Source: Pediatric Nephrology - Category: Urology & Nephrology Source Type: research
The novel coronavirus SARS-CoV-2 (COVID-19) pandemic has crippled vascular surgery practices around the world with almost four million cases and over 260,000 deaths as of May 6, 20201. In order to preserve hospital resources including personal protective equipment and ventilators as well as to “flatten the curve” of exposure of patients and healthcare providers to COVID-19, most centers have imposed limitations on elective/scheduled surgical practices2. For vascular surgeons, this may include limiting procedures such as peripheral arterial disease with claudication, asymptomatic carot id artery disease, small a...
Source: Journal of Vascular Surgery - Category: Surgery Authors: Source Type: research
New recommendations have been added on coordinating support for renal replacement therapy, including discharge planning, for patients with COVID-19 and AKI, and on emergency pathways for maintaining access for patients with end-stage kidney disease already on dialysis.
Source: Current Awareness Service for Health (CASH) - Category: Consumer Health News Source Type: news
More News: COVID-19 | Dialysis | Health | Urology & Nephrology | USA Health